Blue Jet Healthcare Completes QIP, Allocates 15.8 Million Equity Shares at ₹506 Per Share
Blue Jet Healthcare Limited announced that its Investment and Finance Committee approved the closure of a Qualified Institutions Placement (QIP) of equity shares on July 9, 2026. The resolution details the allocation of 15,810,276 Equity Shares to eligible qualified institutional buyers.The approval by the company's committee covered several key aspects related to the placement process. The committee approved the closure of the Issue upon receipt of application forms and funds from the qualified institutional buyers. Furthermore, the committee adopted the Placement Document dated July 9, 2026, and finalized the confirmation of the allocation note intended for the eligible buyers.
The decision regarding the allotment details was formally determined and approved by the Investment and Finance Committee on July 9, 2026. This determination included the specific terms of the placement.
Key financial details of the Equity Shares placement are summarized below:
| Metric | Value |
|---|---|
| Total Equity Shares Allocated | 15,810,276 |
| Issue Price per Share | ₹ 506.00 |
| Premium per Equity Share | ₹ 504.00 |
| Floor Price | ₹ 531.70 |
| Discount from Floor Price | ₹ 25.70 (representing 4.83% of the floor price) |
The company confirmed that all necessary procedures related to the placement were completed and management protocols for the Issue were followed.
BLUEJET Stock Price Movement
On Thursday, shares of Blue Jet Healthcare Limited rallied as the stock closed up by 2.32%, settling at ₹574.50. The equity saw considerable trading volume, with 546,528 shares changing hands during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.